StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.26−0.03 (-0.20%)

Close on Nov 18, 2026Market cap $82.16MP/E 3.3Yield –

Rallybio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Rallybio's market cap was $83.85M on Nov 11, 2026, against $27.30M a year earlier. Over the last 5 years it ranged from $12.86M to $464.94M, with a median of $83.85M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$83.85M+191.4%
2025Dec 31, 2025$28.77M-27.8%
2024Dec 31, 2024$39.83M-55.9%
2023Dec 29, 2023$90.34M-57.2%
2022Dec 30, 2022$210.84M-31.2%
2021Dec 31, 2021$306.52M–

More Rallybio figures

See a number that looks wrong?